JCT  Vol.1 No.3 , September 2010
Management of Unsuspected Gallbladder Cancer in the Era of Minimally Invasive Surgery
ABSTRACT
Gallbladder cancer is the most common malignant tumor of the biliary tract and often diagnosed incidentally during laparoscopic cholecystectomy for gallbladder disease. This underscores the importance of considering the diagnosis of gallbladder cancer when confronted with atypical findings and understanding cancer management guidelines that may impact patient outcome. Potentially curable early stage gallbladder lesions are often missed during preoperative workup and discovered incidentally during difficult cholecystectomy or afterwards on pathologic diagnosis. We will review current strategies to diagnose early stage disease and discuss clinical management issues to optimize the outcome of patients with gallbladder cancer.

Cite this paper
nullP. Wolf, P. Bhargava, C. Pellegrini and P. Wu, "Management of Unsuspected Gallbladder Cancer in the Era of Minimally Invasive Surgery," Journal of Cancer Therapy, Vol. 1 No. 3, 2010, pp. 152-159. doi: 10.4236/jct.2010.13024.
References
[1]   G. F. Whalen, et al., “Laparoscopic Cholecystectomy does not Demonstrably Decrease Survival of Patients with Serendipitously Treated Gallbladder Cancer,” Journal of the American College of Surgeons, Vol. 192, No. 2, 2001, pp. 189195.

[2]   K. Yamaguchi, et al., “Gallbladder Carcinoma in the Era of Laparoscopic Cholecystectomy,” Archives of Surgery, Vol. 131, No. 9, 1996, pp. 981984.

[3]   S. T. Weiland, et al., “Should Suspected Early Gall bladder Cancer be Treated Laparoscopically?” Journal of Gastrointestinal Surgery, Vol. 6, No. 1, 2002, pp. 5056.

[4]   A. Jemal, et al., “Cancer Statistics,” CA: A Cancer Journal for Clinicians, Vol. 58, No. 2, 2008, pp. 7196.

[5]   E. C. LazcanoPonce, et al., “Epidemiology and Molecular Pathology of Gallbladder Cancer,” CA: A Cancer Journal for Clinicians, Vol. 51. No. 6, 2001, pp. 349364.

[6]   N. G. Coburn, et al., “Surgery for Gallbladder Cancer: A PopulationBased Analysis,” Journal of the American College of Surgeons, Vol. 207, No. 3, 2008, pp. 371382.

[7]   A. Csendes, et al., “Number and Size of Stones in Patients with Asymptomatic and Symptomatic Gallstones and Gallbladder Carcinoma: A Prospective Study of 592 Cases,” Journal of Gastrointestinal Surgery, Vol. 4, No. 5, 2000, pp. 481485.

[8]   A. W. Hsing, et al., “Gallstones and the Risk of Biliary Tract Cancer: A PopulationBased Study in China,” British Journal of Cancer, Vol. 97, No. 11, 2007, pp. 1577 1582.

[9]   A. W. Hsing, et al., “Family History of Gallstones and the Risk of Biliary Tract Cancer and Gallstones: A Popu lationBased Study in Shanghai, China,” International Journal of Cancer, Vol. 121, No. 4, 2007, pp. 832838.

[10]   S. C. Cunningham and H. R. Alexander, “Porcelain Gallbladder and Cancer: Ethnicity Explains a Discrepant Literature?” American Journal of Medicine, Vol. 120, No. 4, 2007, pp. e17 e18.

[11]   A. E. Stephen and D. L. Berger, “Carcinoma in the Porcelain Gallbladder: A Relationship Revisited,” Sur gery, Vol. 129, No. 6, 2001, pp. 699703.

[12]   A. H. Kwon, et al., “Laparoscopic Cholecystectomy in Patients with Porcelain Gallbladder Based on the Pre operative Ultrasound Findings,” Hepatogastroentero logy, Vol. 51, No. 58, 2004, pp. 950953.

[13]   M. T. Hueman, C. M. Vollmer, Jr. and T. M. Pawlik, “Evolving Treatment Strategies for Gallbladder Cancer,” Annals of Surgical Oncology, Vol. 16, No. 8, 2009, pp. 21012015.

[14]   A. D. Levy, L. A. Murakata and C. A. Rohrmann, Jr., “Gallbladder Carcinoma: RadiologicPathologic Corre lation,” Radiographics, Vol. 21, No. 2, 2001, pp. 295 314.

[15]   A. Furlan, et al., “Gallbladder Carcinoma Update: Mul timodality Imaging Evaluation, Staging, and Treatment Options,” American Journal of Roentgenology, Vol. 191, No. 5, 2008, pp. 14401447.

[16]   Y. Tsuchiya, “Early Carcinoma of the Gallbladder: Macroscopic Features and US Findings,” Radiology, Vol. 179, No. 1, 1991, pp. 171175.

[17]   A. C. van Breda Vriesman, et al., “Diffuse Gallbladder Wall Thickening: Differential Diagnosis,” American Journal of Roentgenology, Vol. 188, No. 2, 2007, pp. 495501.

[18]   K. Yoshimitsu, et al., “Dynamic MRI of the Gallbladder Lesions: Differentiation of Benign from Malignant,” Journal of Magnetic Resonance Imaging, Vol. 7, No. 4, 1997, pp. 696701.

[19]   E. J. Yun, et al., “Gallbladder Carcinoma and Chronic Cholecystitis: Differentiation with TwoPhase Spiral CT,” Abdom Imaging, Vol. 29, No. 1, 2004, pp. 102108.

[20]   H. Ito, et al., “Polypoid Lesions of the Gallbladder: Diagnosis and Followup,” Journal of the American College of Surgeons, Vol. 208, No. 4, 2009, pp. 570575.

[21]   J. Y. Park, et al., “LongTerm Follow up of Gallbladder Polyps,” Journal of Gastroenterology and Hepatology, Vol. 24, No. 2, 2009, pp. 219222.

[22]   T. Koh, et al., “Differential Diagnosis of Gallbladder Cancer Using Positron Emission Tomography with Fluo rine18Labeled FluoroDeoxyglucose (FDGPET),” Journal of Surgical Oncology, Vol. 84, No. 2, 2003, pp. 7481.

[23]   S. J. Kim, et al., “Accuracy of Preoperative TStaging of Gallbladder Carcinoma Using MDCT,” American Journal of Roentgenology, Vol. 190, No. 1, 2008, pp. 7480.

[24]   N. Kalra, et al., “MDCT in the Staging of Gallbladder Carcinoma,” American Journal of Roentgenology, Vol. 186, No. 3, 2006, pp. 758762.

[25]   J. H. Kim, et al., “Preoperative Evaluation of Gallbladder Carcinoma: Efficacy of Combined Use of MR Imaging, MR Cholangiography, and ContrastEnhanced Dual Phase ThreeDimensional MR Angiography,” Journal of Magnetic Resonance Imaging, Vol. 16, No. 6, 2002, pp. 676684.

[26]   C. U. Corvera, et al., “18FFluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary Cancer,” Journal of the American College of Surgeons, Vol. 206, No. 1, 2008, pp. 5765.

[27]   Y. Shirai, et al., “Radical Surgery for Gallbladder Carcinoma, LongTerm Results,” Annals of Surgery, Vol. 216, No. 5, 1992, pp. 565568.

[28]   M. D’Angelica, et al., “Analysis of the Extent of Re section for Adenocarcinoma of the Gallbladder,” Annals of Surgical Oncology, Vol. 16, No. 4, 2009, pp. 806816.

[29]   H. Onoyama, et al., “Extended Cholecystectomy for Carcinoma of the Gallbladder,” World Journal of Surgery, Vol. 19, No. 5, 1995, pp. 758763.

[30]   D. L. Bartlett, et al., “LongTerm Results after Resection for Gallbladder Cancer. Implications for Staging and Management,” Annals of Surgery, Vol. 224, No. 5, 1996, pp. 639646.

[31]   W. J. Zhang, et al., “Incidental Gallbladder Carcinoma Diagnosed during or after Laparoscopic Cholecystec tomy,” World Journal of Surgery, Vol. 33, No. 12, 2009, pp. 26512656.

[32]   S. B. Choi, et al., “Incidental Gallbladder Cancer Diag nosed Following Laparoscopic Cholecystectomy,” World Journal of Surgery, Vol. 33, No. 12, 2009, pp. 2657 2663.

[33]   R. Steinert, et al., “Laparoscopic Cholecystectomy and Gallbladder Cancer,” Journal of Surgical Oncology, Vol. 93, No. 8, 2006, pp. 682689.

[34]   M. Shoup and Y. Fong, “Surgical Indications and Extent of Resection in Gallbladder Cancer,” Surgery Oncology Clinics of North America, Vol. 11, No. 4, 2002, pp. 985 994.

[35]   S. Kondo, et al., “Extensive Surgery for Carcinoma of the Gallbladder,” British Journal of Surgery, Vol. 89, No. 2, 2002, pp. 179184.

[36]   J. C. Otero, et al., “Gallbladder Cancer: Surgical Results after Cholecystectomy in 25 Patients with Lamina Propria Invasion and 26 Patients with Muscular Layer Invasion,” Journal of HepatoBiliaryPancreatic Surgery, Vol. 13, No. 6, 2006, pp. 562566.

[37]   K. M. Hardiman and B. C. Sheppard, “What to do when the Pathology from Last Week’s Laparoscopic Chole cystectomy is Malignant and T1 or T2,” Journal of Gastrointestinal Surgery, Vol. 13, No. 11, 2009, pp. 2037 2039.

[38]   P. J. Shukla, et al., “Revision Surgery for Incidental Gallbladder Cancer: Factors Influencing Operability and Further Evidence for T1b Tumours,” Health Promotion Board (Oxford), 2008, Vol. 10, No. 1, pp. 4347.

[39]   M. Goldfarb, S. Brower and S. D. Schwaitzberg, “Mini mally Invasive Surgery and Cancer: Controversies Part 1,” Surgical Endoscopy, Vol. 24, No. 2, 2010, pp. 304 334.

[40]   J. Fleshman, et al., “Laparoscopic Colectomy for Cancer is not Inferior to Open Surgery Based on 5Year Data from the COST Study Group Trial,” Annals of Surgery, Vol. 246, No. 4, 2007, pp. 655662.

[41]   The Clinical Outcomes of Surgical Therapy Study Group, “A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer,” New England Journal of Medicine, Vol. 350, No. 20, 2004, pp. 20502059.

[42]   J. J. Carter and R. L. Whelan, “The Immunologic Consequences of Laparoscopy in Oncology,” Surgery Oncology Clinics of North America, Vol. 10, No. 3, 2001, pp. 655677.

[43]   A. Belizon, et al., “Persistent Elevation of Plasma Vascular Endothelial Growth Factor Levels during the First Month after Minimally Invasive Colorectal Re section,” Surgical Endoscopy, Vol. 22, No. 2, 2008, pp. 287297.

[44]   J. M. Foster, et al., “Gallbladder Cancer: Defining the Indications for Primary Radical Resection and Radical ReResection,” Annals of Surgical Oncology, 2007, Vol. 14, No. 2, pp. 833840.

[45]   T. Wakai, Y. Shirai and K. Hatakeyama, “Radical Second Resection Provides Survival Benefit for Patients with T2 Gallbladder Carcinoma First Discovered after Laparo scopic Cholecystectomy,” World Journal of Surgery, Vol. 26, No. 7, 2002, pp. 867871.

[46]   H. Onoyama, et al., “Does Radical Resection Improve the Survival in Patients with Carcinoma of the Gallbladder who are 75 Years Old and Older?” World Journal of Surgery, Vol. 26, No. 11, 2002, pp. 13151318.

[47]   K. Ouchi, J. Mikuni and Y. Kakugawa, “Laparoscopic Cholecystectomy for Gallbladder Carcinoma: Results of a Japanese Survey of 498 Patients,” Journal of HepatoBili aryPancreatic Surgery, Vol. 9, No. 2, 2002, pp. 256260.

[48]   Y. Fong, W. Jarnagin and L. H. Blumgart, “Gallbladder Cancer: Comparison of Patients Presenting Initially for Definitive Operation with Those Presenting after Prior Noncurative Intervention,” Annals of Surgery, Vol. 232, No. 4, 2000, pp. 557569.

[49]   S. Y. Cho, et al., “Comparative Analysis between Clinical Outcomes of Primary Radical Resection and Second Completion Radical Resection for T2 Gallbladder Cancer: SingleCenter Experience,” World Journal of Surgery, Vol. 34, No. 7, 2010, pp. 15721578.

[50]   S. P. Shih, et al., “Gallbladder Cancer: The Role of Laparoscopy and Radical Resection,” Annals of Surgery, Vol. 245, No. 6, 2007, pp. 893901.

[51]   P. Sooriakumaran, et al., “PortSite Metastasis after Laparoscopic Surgery: What Causes them and What can be Done to Reduce their Incidence?” British Journal of Urology International, Vol. 103, No. 9, 2009, pp. 1150 1153.

[52]   S. Towfigh, et al., “Porcelain Gallbladder is not Asso ciated with Gallbladder Carcinoma,” American Surgeon, Vol. 67, No. 1, 2001, pp. 710.

[53]   K. Tsukada, et al., “Lymph Node Spread from Carcinoma of the Gallbladder,” Cancer, Vol. 80, No. 4, 1997, pp. 661667.

[54]   T. M. Pawlik, et al., “Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implica tions for ReResection,” Journal of Gastrointestinal Surgery, Vol. 11, No. 11, 2007, pp. 14781486.

[55]   T. Takada, et al., “Is Postoperative Adjuvant Chemo therapy Useful for Gallbladder Carcinoma? A Phase III Multicenter Prospective Randomized Controlled Trial in Patients with Resected Pancreaticobiliary Carcinoma,” Cancer, Vol. 95, No. 8, 2002, pp. 16851695.

 
 
Top